发明名称 |
СПОСОБ ЛЕЧЕНИЯ НЕОВАСКУЛЯРНОЙ ГЛАУКОМЫ |
摘要 |
FIELD: medicine. ^ SUBSTANCE: method involves translimbally exposing anterior chamber neovascularization angle projection zone to low intensity laser radiation field-by-field at wavelength of 633 nm at a dose of 2.5 J or at wavelength of 890 nm at a dose of 1.2 J. Water-soluble chlorine row photosensitizer dosage form is intravenously introduced at a bolus dose of 0.8-1.1 mg/kg. Newly formed blood vessels are exposed to radiation in 15-20 min after having accomplished photosensitizer introduction, field-by-field with diameter not greater than 3 mm and wavelength corresponding to maximum luminous flow absorption by the photosensitizer. Power density is equal to 50-80 J/cm2. Irradiation is applied with neighboring fields overlap by 5% of area. The laser field covers anterior chamber angle structures and iris root zone. Irradiation zone is not to exceed 180° per one session along anterior chamber angle length. The treatment is completely repeated in 2-3 weeks in the zone remaining intact during the first session. ^ EFFECT: dosed action; reduced risk of traumatic complications; stable ophthalmotone and anterior chamber angle neovascularization regress. |
申请公布号 |
RU2005106395(A) |
申请公布日期 |
2006.08.20 |
申请号 |
RU20050106395 |
申请日期 |
2005.03.10 |
申请人 |
Государственное Учреждение Межотраслевой Научно-технический комплекс "Микрохирурги глаза" им. акад. С.Н. Федорова Министерства Здравоохранени Российской Федерации (RU) |
发明人 |
Белый Юрий Александрович (RU);Терещенко Александр Владимирович (RU);Володин Павел Львович (RU);Каплан Михаил Александрович (RU);Пупкова Тать на Николаевна (RU) |
分类号 |
A61F9/00;A61K31/409;A61N5/067 |
主分类号 |
A61F9/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|